Concurrent Investment Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
34,405
+17,105
+99% +$1.61M 0.02% 652
2026
Q1
$2.05M Buy
17,300
+552
+3% +$68.3K 0.02% 610
2025
Q4
$2.11M Sell
16,748
-3,198
-16% -$417K 0.02% 556
2025
Q3
$2.92M Sell
19,946
-1,051
-5% -$159K 0.05% 362
2025
Q2
$3.27M Buy
20,997
+3,191
+18% +$506K 0.06% 308
2025
Q1
$2.93M Buy
17,806
+3,041
+21% +$506K 0.07% 288
2024
Q4
$2.41M Buy
14,765
+5,091
+53% +$910K 0.06% 288
2024
Q3
$1.89M Buy
9,674
+635
+7% +$117K 0.06% 327
2024
Q2
$1.57M Buy
9,039
+1,507
+20% +$251K 0.05% 336
2024
Q1
$1.27M Buy
7,532
+3,754
+99% +$703K 0.05% 330
2023
Q4
$746K Buy
+3,778
New +$669K 0.04% 394

Other funds holding ZTS

Concurrent Investment Advisors's ZTS Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Zoetis (ZTS) stake by 99% in Q2 2026, buying an estimated $1.61M and bringing the position to 34,405 shares worth $2.47M. The position accounts for 0.02% of the portfolio, ranked #652.

Concurrent Investment Advisors first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.27M in Q2 2025. 1,435 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Concurrent Investment Advisors held 34,405 shares of Zoetis worth $2.47M as of Q2 2026.
  • Concurrent Investment Advisors bought 17,105 Zoetis shares in Q2 2026, an estimated $1.61M.
  • Zoetis made up 0.02% of Concurrent Investment Advisors's portfolio in Q2 2026, its #652 holding.
  • Concurrent Investment Advisors first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Zoetis position peaked at $3.27M in Q2 2025.
  • 1,435 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.